(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SALMET-VEC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SALMET-VEC

ST13

US500000088697201

Class

5

Filing

88697201

Registration

6429132

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

07/20/2026

Trademark type

Combined

Nice classes

5

Filing date

11/18/2019

Registration date

07/20/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/20/2021

Last transaction

07/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/12/2020

First use in commerce

11/12/2020

Drawing code

3

Owner type

16

Owner location

Guangzhou, CN

Examiner

LAWRENCE, SUSAN KASTRINER

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "SALMET-VEC" above which are four Chinese characters.

Holders and representatives

Holders

Guangzhou Sinogen Pharmaceutical Co., Ltd.

Representatives

Kevin O'Keefe

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant partgene therapy substances

Publications

History of USPTO decisions and trademark events.

33 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/20/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/07/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/07/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/07/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/20/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/15/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/14/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/11/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/02/2021

GNRT

NON-FINAL ACTION E-MAILED

03/02/2021

CNRT

SU - NON-FINAL ACTION - WRITTEN

03/02/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/26/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/26/2021

IUAF

USE AMENDMENT FILED

01/06/2021

EISU

TEAS STATEMENT OF USE RECEIVED

01/06/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/12/2020

PUBO

PUBLISHED FOR OPPOSITION

05/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/22/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/03/2020

ALIE

ASSIGNED TO LIE

04/01/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/25/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/22/2020

GNRT

NON-FINAL ACTION E-MAILED

02/22/2020

CNRT

NON-FINAL ACTION WRITTEN

02/22/2020

DOCK

ASSIGNED TO EXAMINER

02/20/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/25/2019

NWAP

NEW APPLICATION ENTERED

11/21/2019

Continuous trademark protection

Get notified about every new filing that threatens SALMET-VEC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.